Expand PALI Menu
PALI MENU

PALI Latest Press Releases

-- September 3, 2026 --

Palisade Bio to Participate in Upcoming Investor Conferences Globe Newswire 9:00 AM

-- August 10, 2026 --

Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development Globe Newswire 4:20 PM

-- July 10, 2026 --

Palisade Bio to Participate in the Leerink Partners Therapeutics Forum Globe Newswire 9:00 AM

-- June 29, 2026 --

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis Globe Newswire 8:30 AM

-- June 11, 2026 --

Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors Globe Newswire 8:45 AM

-- June 9, 2026 --

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn's Disease at New York Academy of Sciences Symposium Globe Newswire 8:45 AM

-- May 27, 2026 --

Palisade Bio to Participate in the Jefferies Global Healthcare Conference Globe Newswire 9:00 AM

-- May 12, 2026 --

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 Globe Newswire 4:15 PM

-- May 5, 2026 --

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis Globe Newswire 8:30 AM

-- April 16, 2026 --

Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 Globe Newswire 8:50 AM

-- April 8, 2026 --

Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes